1. Chat Live with Access 360
logo
  1. For US Health Care Providers
  2. Go to Patient Site
  3. (acalabrutinib) 100mg capsules

    Prescribing InformationGo to CALQUENCE website

  • Home
  • Support Services
    • Benefits Investigation
    • Prior Authorization
    • Pharmacy Research
    • Pharmacy Coordination
    • Follow-Up Support
    • Appeal Support
    • Alternative Coverage
    • Coding & Reimbursement
    • Affordability Support
  • Forms & Resources
    • Access 360 Portal
    • Downloads
  • About Access 360
  • Contact Information

Site Map

  1. Home
  2. HCP
  3. HCP branded Calquence
  4. Site Map

AstraZeneca Access 360™ Home Page

HCP Site

  • Home
  • Support Services
    • Benefits Investigation
    • Prior Authorization
    • Pharmacy Research
    • Pharmacy Coordination
    • Follow-Up Support
    • Appeal Support
    • Alternative Coverage
    • Coding and Reimbursement
    • Affordability Support
  • Forms & Resources
    • Access 360 Portal
    • Downloads
  • About AstraZeneca Access 360™
  • Contact Information
  1. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088.

  2. Contact Us
  3. AstraZeneca US Corporate Site
  4. Privacy Notice
  5. Legal Statement
  6. CALQUENCE Site Map
  7. ARIMIDEX, CALQUENCE, CASODEX, FASLODEX, FLUMIST, IMFINZI, IRESSA, LYNPARZA, SYNAGIS and TAGRISSO are registered trademarks, FASENRA and AstraZeneca Access 360 are trademarks of the AstraZeneca group of companies. All other trademarks are property of their respective owners.

  8. This site is intended for US audiences only.

    ARIMIDEX, CALQUENCE, CASODEX, FASLODEX, FLUMIST, IMFINZI, IRESSA, LYNPARZA, SYNAGIS and TAGRISSO are registered trademarks, FASENRA and AstraZeneca Access 360 are trademarks of the AstraZeneca group of companies. All other trademarks are property of their respective owners.

    ©2017 AstraZeneca. All rights reserved. US-6979; US-16867 Last Updated 12/17

  9. AstraZeneca